0.1172 USD
-0.01 (-8.44%)
0.1072 USD
-0.01 (-8.53%)
ChartMill assigns a Buy % Consensus number of 78% to SYRS. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 10.71. This target is 9038.23% above the current price.
SYRS was analyzed by 9 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about SYRS.
In the previous month the buy percentage consensus was at a similar level.
SYRS was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-11-13 | TD Cowen | Downgrade | Buy -> Hold |
| 2024-11-13 | Brookline Capital | Downgrade | Buy -> Hold |
| 2024-11-13 | JMP Securities | Downgrade | Market Outperform -> Market Perform |
| 2024-11-13 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2024-11-01 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-13 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2024-08-13 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2024-08-13 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-08-01 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-26 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-03 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2024-04-01 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-10-03 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2023-08-09 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-11 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2023-05-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-03-03 | Oppenheimer | Maintains | Outperform |
| 2023-03-03 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-01-05 | Piper Sandler | Maintains | Overweight |
| 2022-11-15 | JMP Securities | Maintains | Market Outperform |
| 2022-11-15 | Oppenheimer | Maintains | Outperform |
| 2022-11-15 | HC Wainwright & Co. | Maintains | Buy |
| 2022-08-10 | Oppenheimer | Maintains | Outperform |
| 2022-07-12 | HC Wainwright & Co. | Maintains | Buy |
| 2022-05-17 | Alliance Global Partners | Maintains | Buy |
| 2022-05-17 | HC Wainwright & Co. | Maintains | Buy |
| 2021-09-23 | Roth Capital | Maintains | Buy |
SYROS PHARMACEUTICALS INC / SYRS FAQ
What is the average price target for SYROS PHARMACEUTICALS INC (SYRS) stock?
9 analysts have analysed SYRS and the average price target is 10.71 USD. This implies a price increase of 9038.23% is expected in the next year compared to the current price of 0.1172.
What is the consensus rating for SYROS PHARMACEUTICALS INC (SYRS) stock?
The consensus rating for SYROS PHARMACEUTICALS INC (SYRS) is 77.7778 / 100 . This indicates that analysts generally have a positive outlook on the stock.